Jami Rubin, Director at Relay Therapeutics, Inc. (RLAY), bought 25,000 shares at $20.00 ($500K) on 2020-07-20, disclosed to the SEC on 2020-07-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.